The Role of Exosomal miRNAs in Promoting Tumor Metastasis: A Molecular Insight

Authors

  • Nitish Kumar
  • Anup Negi
  • Diksha Mehra
  • Farah Khan

Keywords:

Exosomal miRNAs, Tumor metastasis, miR-21, miR-210, Cross-national analysis, Biomarkers

Abstract

Exosomal miRNAs, such as miR-21, miR-10b, and miR-210, play critical roles in tumor progression, particularly in promoting metastasis through tumor microenvironment modulation, immune evasion, and angiogenesis. This study examines the molecular mechanisms and cross-national variability in exosomal miRNA expression linked to metastatic potential across diverse cancer types. We collected exosomal samples from breast, lung, and colorectal cancer patients at various metastatic stages from three countries. Quantitative RT-PCR assessed the expression levels of miR-21, miR-10b, and miR-210. Statistical analyses, including correlation tests and multivariate models, were employed to explore the relationship between miRNA levels and metastatic stages. Elevated levels of miR-21 and miR-210 were positively correlated with increased metastatic potential across all cancer types. Notably, miR-21 showed significant association with advanced stages in breast and colorectal cancers, while miR-210 was predominantly elevated in lung cancer metastases. Cross-national analyses revealed variances in miRNA expression, suggesting potential influences of genetic and environmental factors. Our findings underscore the pivotal role of exosomal miRNAs as both biomarkers and active facilitators of tumor metastasis. The cross-national differences highlight the need for personalized approaches in cancer treatment. Future studies should focus on targeted miRNA inhibition strategies and explore environmental factors affecting miRNA expression.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Chen, G., Huang, A. C., Zhang, W., et al. (2018). Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature, 560(7718), 382–386.

Hoshino, A., Costa-Silva, B., Shen, T. L., et al. (2015). Tumor exosome integrins determine organotropic metastasis. Nature, 527(7578), 329–335.

Kalluri, R., & LeBleu, V. S. (2020). The biology, function, and biomedical applications of exosomes. Science, 367(6478), eaau6977.

Shao X, Hua S, Feng T, Ocansey DKW, Yin L. Hypoxia-Regulated Tumor-Derived Exosomes, and Tumor Progression: A Focus on Immune Evasion. Int J Mol Sci. 2022 Oct 4;23(19):11789. doi: 10.3390/ijms231911789. PMID: 36233088; PMCID: PMC9570495.

Peinado, H., Lavotshkin, S., & Lyden, D. (2012). Pre-metastatic niches: Organ-specific homes for metastases. Nature Reviews Cancer, 12(1), 39–46.

Svensson, K. J., Kucharzewska, P., Christianson, H. C., et al. (2011). Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated VEGF and IL-6 production. PLoS ONE, 6(2), e19773.

Valadi, H., Ekström, K., Bossios, A., et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9(6), 654–659.

Wang, M., Yu, F., Ding, H., & Wang, J. (2019). Exosome-based nanotherapeutics: Emerging frontiers in anti-cancer drug delivery. Frontiers in Pharmacology, 10, 713.

Chuang YT, Tang JY, Shiau JP, Yen CY, Chang FR, Yang KH, Hou MF, Farooqi AA, Chang HW. Modulating Effects of Cancer-Derived Exosomal miRNAs and Exosomal Processing by Natural Products. Cancers (Basel). 2023 Jan 3;15(1):318. Doi: 10.3390/cancers15010318. PMID: 36612314; PMCID: PMC9818271.

Duréndez-Sáez E, Torres-Martinez S, Calabuig-Fariñas S, Meri-Abad M, Ferrero-Gimeno M, Camps C. Exosomal microRNAs in non-small cell lung cancer. Transl Cancer Res. 2021 Jun;10(6):3128-3139. doi: 10.21037/tcr-20-2815. PMID: 35116621; PMCID: PMC8798604.

Downloads

Published

2025-05-05

How to Cite

1.
Kumar N, Negi A, Mehra D, Khan F. The Role of Exosomal miRNAs in Promoting Tumor Metastasis: A Molecular Insight. J Neonatal Surg [Internet]. 2025May5 [cited 2025Oct.23];14(7):98-105. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/5119